COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 753: Articles 7521-7530  | Next

Loss of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months
Lea, S., Simeonsson, K., Kipp, A., McNeill, C., Wilcox, L., Irish, W., Morris, H., Diaz, O., Fallon, J., Roper, R. L.
10.1101/2022.07.15.22277688 — Posted: 2022-07-18
Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages
Bhiman, J. N., Richardson, S. I., Lambson, B. E., Kgagudi, P., Mzindle, N., Kaldine, H., Crowther, C., Gray, G., Bekker, L.-G., Koen, A., Fairlie, L., Fouche, L., Bhorat, Q., Dheda, K., Tameris, M., Masilela, M. S. L., Hoosain, Z., Singh, N., Hanley, S., Archary, M., Louw, C., Grobbelaar, C., Lalloo, U., Joseph, N., Kruger, G., Shinde, V., Bennett, C., Glenn, G., Madhi, S., Moore, P. L.
10.1101/2022.07.14.500148 — Posted: 2022-07-17
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq
Sunshine, S., Puschnik, A. S., Replogle, J. M., Laurie, M. T., Liu, J., Zha, B. S., Nunez, J. K., Byrum, J. R., McMorrow, A. H., Frieman, M. B., Winkler, J., Qiu, X., Rosenberg, O. S., Leonetti, M. D., Ye, C. J., Weissman, J. S., DeRisi, J. L., Hein, M. Y.
10.1101/2022.07.15.500120 — Posted: 2022-07-17
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Bojkova, D., Reus, P., Panosch, L., Bechtel, M., Rothenburger, T., Kandler, J., Pfeiffer, A., Wagner, J. U., Shumliakivska, M., Dimmeler, S., Olmer, R., Martin, U., Vondran, F., Toptan, T., Rothweiler, F., Zehner, R., Rabenau, H., Osman, K. L., Pullan, S. T., Carroll, M. T., Stack, R., Ciesek, S., Wass, M. N., Michaelis, M., Cinatl, J.
10.1101/2022.07.17.500346 — Posted: 2022-07-17
Differential symptoms among COVID-19 outpatients before and during periods of SARS-CoV-2 Omicron variant dominance in Blantyre, Malawi: a prospective observational study
Chibwana, M. G., Thole, H. W., Anscombe, C., Ashton, P. M., Green, E., Barnes, K. G., Cornick, J., Turner, A., Witte, D., Nthala, S., Thom, C., Kanyandula, F., Ainani, A., Mtike, N., Tambala, H., N'goma, V., Mwafulirwa, D., Asima, E., Morton, B., Gmeiner, M., Gundah, Z., Kawalazira, G., French, N., Feasey, N., Heyderman, R. S., Swarthout, T. D., Jambo, K. C.
10.1101/2022.07.15.22277665 — Posted: 2022-07-17
COVID-19 Prevention at Institutions of Higher Education, United States, 2020 -- 2021: Implementation of Nonpharmaceutical Interventions
Moreland, S., Zviedrite, N., Ahmed, F., Uzicanin, A.
10.1101/2022.07.15.22277675 — Posted: 2022-07-17
Attitudes toward COVID-19 pandemic among fully vaccinated individuals: evidence from Greece two years after the pandemic
Galanis, P. A., Vraka, I., Katsiroumpa, A., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Mariolis-Sapsakos, T., Kaitelidou, D.
10.1101/2022.07.16.22277705 — Posted: 2022-07-17
Global patterns and drivers of influenza decline during the COVID-19 pandemic
Bonacina, F., Boëlle, P.-Y., Colizza, V., Lopez, O., Thomas, M., Poletto, C.
10.1101/2022.07.15.22277497 — Posted: 2022-07-17
Ethnic homophily affects vaccine prioritization strategies
Kadelka, C., Islam, M. R., McCombs, A., Alston, J., Morton, N.
10.1101/2022.07.15.22277696 — Posted: 2022-07-17
Influence of vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity
Jolliffe, D. A., Vivaldi, G., Chambers, E. S., Cai, W., Li, W., Faustini, S. E., Gibbons, J. M., Pade, C., Richter, A., McKnight, A., Martineau, A. R.
10.1101/2022.07.15.22277678 — Posted: 2022-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).